TetraLogic Pharmaceuticals Corp
OTC:TLOG
TetraLogic Pharmaceuticals Corp
OTC:TLOG
Price:
0.0001
USD
Market Closed
Market Cap:
$24.5
Balance Sheet
Balance Sheet Decomposition
TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corp
Balance Sheet Decomposition is not available for
TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corp
Balance Sheet
TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corp
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
10
|
5
|
55
|
13
|
15
|
|
| Cash Equivalents |
10
|
5
|
55
|
13
|
15
|
|
| Short-Term Investments |
6
|
0
|
0
|
41
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
2
|
|
| Total Current Assets |
16
|
5
|
55
|
55
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
42
|
42
|
|
| Goodwill |
0
|
0
|
0
|
17
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
0
|
|
| Other Assets |
0
|
0
|
0
|
17
|
0
|
|
| Total Assets |
16
N/A
|
5
-70%
|
56
+1 036%
|
117
+110%
|
64
-45%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
2
|
2
|
3
|
4
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
5
|
5
|
4
|
|
| Long-Term Debt |
0
|
5
|
0
|
27
|
28
|
|
| Deferred Income Tax |
0
|
0
|
0
|
17
|
17
|
|
| Other Liabilities |
0
|
0
|
0
|
34
|
21
|
|
| Total Liabilities |
4
N/A
|
8
+124%
|
5
-37%
|
83
+1 580%
|
70
-16%
|
|
| Equity | ||||||
| Common Stock |
65
|
65
|
0
|
0
|
0
|
|
| Retained Earnings |
54
|
70
|
90
|
126
|
176
|
|
| Additional Paid In Capital |
1
|
1
|
140
|
159
|
170
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
13
N/A
|
3
N/A
|
51
N/A
|
33
-34%
|
6
N/A
|
|
| Total Liabilities & Equity |
16
N/A
|
5
-70%
|
56
+1 036%
|
117
+110%
|
64
-45%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
21
|
21
|
22
|
22
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
